Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Mercury Laboratories Ltd (MRCU)

BSE
Currency in INR
955.00
+2.05(+0.22%)
Closed
MRCU Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
Fair Value
Day's Range
935.30974.65
52 wk Range
721.151,303.00
Key Statistics
Edit
Bid/Ask
927.00 / 955.00
Prev. Close
952.95
Open
952.95
Day's Range
935.3-974.65
52 wk Range
721.15-1,303
Volume
48
Average Volume (3m)
472
1-Year Change
20.89%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MRCU Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has maintained dividend payments for 10 consecutive years
Show more

Mercury Laboratories Ltd Company Profile

Mercury Laboratories Limited develops, manufactures, markets, distributes, and sells pharmaceutical drugs, medicines, and formulations for mother and child healthcare in India and internationally. The company offers analgesic, anti-inflammatory, anti-pyretic, anthelmintic, antibiotic, anti-coagulant, anti-platelet, bleeding agent, anti-fungal, anti-hypertensive, anti-malarial, cardiovascular system, central nervous system, eye, gastro-intestinal system, hypoglycemic/anti-diabetic, multivitamin, protein supplement, respiratory system, anti-allergic, steroids, urinary system, uterine stimulant, and other drugs; and formulations, including tablets, oral liquids, injections, small volume parenterals, and eye/ear drops. It also provides pharmaceutical products for PCOS and uterine disorders, galactagogue, haemostat, iron, pain management, preterm labor management, antiemetic, PPI, vitamin K1, zinc supplement, vitamin D3, digestive enzyme, promolact, and childcare, as well as products for gynec, pediatric, surgeon, and physician applications. The company export its products comprising anti-inflammatory, antimalarial, digestive, hypoglycemic, multivitamin, CNS, pain management, gynec, CVS, cough and cold, miscellaneous, and other formulations, as well as antibiotic, antifungal, and antiviral formulations to approximately 25 countries, including the Philippines, Myanmar, Sri Lanka, Vietnam, Cambodia, D.R. Congo, Ghana, Nigeria, Mozambique, Zambia, Kenya, lvory Coast, Mauritania, Burundi, Togo, Guatemala, Costa Rica, Peru, Ecuador, the United Kingdom, the United States, Moldova, and Jamaica. Mercury Laboratories Limited was founded in 1962 and is headquartered in Vadodara, India.

Employees
482
Market
India

Compare MRCU to Peers and Sector

Metrics to compare
MRCU
Peers
Sector
Relationship
P/E Ratio
28.7x18.1x−0.7x
PEG Ratio
1.970.190.00
Price/Book
2.2x2.3x2.6x
Price / LTM Sales
1.7x2.6x3.2x
Upside (Analyst Target)
-5.9%40.8%
Fair Value Upside
Unlock−6.5%5.7%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 33.24
Dividend Yield
0.37%
Industry Median 0.71%
Annualised payout
3.5000
Paid annually
5-Years Growth
-
Growth Streak

FAQ

What Is the Mercury Laboratories Ltd (MRCU) Stock Price Today?

The Mercury Laboratories Ltd stock price today is 955.00.

What Stock Exchange Does Mercury Laboratories Ltd Trade On?

Mercury Laboratories Ltd is listed and trades on the BSE stock exchange.

What Is the Stock Symbol for Mercury Laboratories Ltd?

The stock symbol for Mercury Laboratories Ltd is "MRCU."

Does Mercury Laboratories Ltd Pay Dividends? What’s The Current Dividend Yield?

The Mercury Laboratories Ltd dividend yield is 0.37%.

What Is the Mercury Laboratories Ltd Market Cap?

As of today, Mercury Laboratories Ltd market cap is 1.15B.

What is Mercury Laboratories Ltd Earnings Per Share?

The Mercury Laboratories Ltd EPS is 33.24.

What Is the Next Mercury Laboratories Ltd Earnings Date?

Mercury Laboratories Ltd will release its next earnings report on 03 Feb 2025.

From a Technical Analysis Perspective, Is MRCU a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.